Evaluation of the TheraNova Neuromodulation System to Provide Durable Relief of Overactive Bladder Symptoms

Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan

NCT03059134 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the The Neuromodulation System for the Treatment of Overactive Bladder Symptoms

NCT04999657 ·Status: COMPLETED ·Phase: NA

Efficacy of Transcutaneous Versus Percutaneous Posterior Tibial Nerve Stimulation in the Overactive Bladder.

NCT04483817 ·Status: UNKNOWN ·Phase: NA

A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB)

NCT03492281 ·Status: COMPLETED ·Phase: PHASE3

Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan

NCT03044912 ·Status: UNKNOWN ·Phase: PHASE3

Role of Combination Therapy in Women With Refractory Overactive Bladder

NCT06438861 ·Status: WITHDRAWN ·Phase: NA

TPTNS: Home vs Hospital Treatment for Overactive Bladder

NCT03727711 ·Status: UNKNOWN ·Phase: NA

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

NCT06511141 ·Status: RECRUITING ·Phase: NA

Safety and Efficacy of MK0594 to Treat Overactive Bladder (0594-003)

NCT00290563 ·Status: COMPLETED ·Phase: PHASE2

Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection

NCT05719285 ·Status: COMPLETED ·Phase: PHASE4

Open Label Study to Evaluate the Efficacy of the Home Based Electrical Transcutaneous URIS I in the Treatment of Overactive Bladder (OAB).

NCT05211193 ·Status: COMPLETED

Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OAB

NCT02485067 ·Status: COMPLETED ·Phase: PHASE3

Mirabegron Combined With Behavioral Intervention for Overactive Bladder：a Prospective Multicenter Randomized Controlled Clinical Study

NCT05452434 ·Status: UNKNOWN ·Phase: PHASE4

Evaluating a Digital Intervention for Overactive Bladder

NCT05170100 ·Status: COMPLETED ·Phase: NA

A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

NCT00662909 ·Status: COMPLETED ·Phase: PHASE3

Safety and Tolerability of TAR-302-5018 in Subjects With Neurogenic Detrusor Overactivity Resulting From Spinal Cord Injury

NCT03168828 ·Status: COMPLETED ·Phase: PHASE1

Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

NCT00688688 ·Status: COMPLETED ·Phase: PHASE3

A Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological Condition

NCT00224029 ·Status: COMPLETED ·Phase: PHASE4

A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder

NCT00685113 ·Status: COMPLETED ·Phase: PHASE3

Acupuncture Combined With Mirabegron in the Treatment of OAB

NCT06181019 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Efficacy, Tolerability and Impact on Quality of Life of Propiverine in Patients With Overactive Bladder Syndrome

NCT02024945 ·Status: COMPLETED

InSite for Over Active Bladder

NCT00547378 ·Status: COMPLETED ·Phase: PHASE4

Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

NCT00689104 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of AGN-214868 in Patients With Idiopathic Overactive Bladder and Urinary Incontinence

NCT01157377 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Intradetrusor AbobotulinumtoxinA and IncobotulinumtoxinA in Women With Overactive Bladder

NCT06250543 ·Status: COMPLETED ·Phase: PHASE4